Related Experiment Video
Updated: Dec 18, 2025
09:40
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
5.9K
Circular RNAs and Glioma: Small Molecule with Big Actions
Abbas Abi1, Kamran Ghaedi2, Alireza Khosravi3
1Department of Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Current Molecular Medicine
|June 11, 2020
Summary
Circular RNAs play a key role in glioma pathogenesis. Understanding these circular RNAs (circRNAs) could lead to new therapeutic strategies for glioma, a deadly brain tumor.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Glioma is a highly fatal brain tumor with poor survival rates despite advances in treatment.
- Current therapeutic approaches for glioma, including chemotherapy, radiation, and surgery, have not significantly improved patient outcomes.
- Genetic and epigenetic modifications are critical for understanding glioma development and identifying new therapeutic targets.
Purpose of the Study:
- To summarize the current understanding of circular RNAs (circRNAs) involved in glioma pathogenesis.
- To highlight the role of circRNAs as potential biomarkers and therapeutic targets in glioma.
- To explore how circRNAs regulate key biological processes in glioma, such as migration, invasion, and apoptosis.
Main Methods:
- Literature review of studies investigating circular RNAs in glioma.
- Analysis of reported functions and mechanisms of circRNAs in glioma development.
- Synthesis of data on tissue specificity and gene regulation by circRNAs.
Main Results:
- Circular RNAs are implicated in various stages of glioma progression.
- Specific circRNAs have been identified to influence glioma cell migration, invasion, and apoptosis.
- CircRNAs exhibit tissue-specific expression patterns, making them potential diagnostic markers.
Conclusions:
- Circular RNAs represent a promising area for developing novel therapeutic strategies for glioma.
- Further research into circRNA functions and regulatory networks is crucial for advancing glioma treatment.
- Targeting circRNAs could offer new avenues for improving patient survival in glioma.
More Related Videos
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.0K
09:06MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
241
Related Concept Videos
02:30siRNA - Small Interfering RNAs
18.1K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.1K
01:24Small GTPases - Ras and Rho
5.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.0K
01:23RNA Interference
27.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.6K
02:15Experimental RNAi
7.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.1K
02:47Ribozymes
13.2K
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can...
Ribozymes can...
13.2K
02:38The Ras Gene
6.9K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.9K